177Lu-labeled NY108 SPECT Imaging in Patients
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
The Active Surveillance Study
- Status
- RECRUITING
- Phase
- N/A
PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study
- Status
- COMPLETED
- Phase
- PHASE2
Preop Laxatives in Robotic Urologic Surgery
- Status
- RECRUITING
- Phase
- PHASE4
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
- Status
- COMPLETED
- Phase
- PHASE4
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
A Digital Therapeutic Solution for Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Improving Decision-Making for Low Health Literate Prostate CA Patients
- Status
- COMPLETED
- Phase
- NA
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- Status
- RECRUITING
- Phase
- PHASE3
Real-Life Pilot Feasibility Study (LC_RLP)
- Status
- COMPLETED
- Phase
- NA
Measuring Oncological Value of Exercise and Statin
- Status
- RECRUITING
- Phase
- PHASE3
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
- Status
- RECRUITING
- Phase
- PHASE2
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.
- Status
- RECRUITING
- Phase
- NA
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
- Status
- RECRUITING
- Phase
- PHASE3
Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1